FDA budget mark-up
This article was originally published in The Gray Sheet
Executive Summary
Agency's fiscal year 1999 budget will be marked up by the Senate Appropriations/Agriculture Subcommittee June 9 and by the House Appropriations/Agriculture Subcommitee on June 10. FDA's proposed budget, which calls for flat funding compared to FY 1998 for the Center for Devices and Radiological Health, was reviewed by the House Subcommittee Feb. 25 ("The Gray Sheet" March 2, p. 10) and the Senate March 31 ("The Gray Sheet" April 6, p. 5)...
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.